STOCK TITAN

CEL-SCI Corp (CVM) CEO Geert Kersten reports insider purchase of 8,389 shares

Filing Impact
(Neutral)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

CEL-SCI Corp (CVM) reported an insider stock purchase by its Chief Executive Officer and director, Geert Kersten. On December 4, 2025, Kersten bought 8,389 shares of CEL-SCI common stock in an open market-style transaction coded as a purchase. The filing reports a purchase price of $5.96 per share, matching the company’s closing price on December 3, 2025, which the company used as the most recent closing price available.

Following this transaction, Kersten beneficially owns 81,794 shares of CEL-SCI common stock directly. The filing is made on Form 4, which discloses changes in ownership by company insiders such as directors and executive officers.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KERSTEN GEERT R

(Last) (First) (Middle)
8229 BOONE BLVD
STE 802

(Street)
VIENNA VA 22182

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CEL SCI CORP [ CVM ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 12/04/2025 P 8,389(1) A $5.96 81,794 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On December 4, 2025, Mr. Kersten purchased 8,389 shares of restricted stock directly from the Company at the closing price on December 3, 2025, the most recent closing price available.
Geert Kersten 12/05/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did CEL-SCI Corp (CVM) report on this Form 4?

The company reported that Geert Kersten, its Chief Executive Officer and director, purchased 8,389 shares of CEL-SCI common stock on December 4, 2025.

At what price did Geert Kersten buy CEL-SCI (CVM) shares?

Geert Kersten purchased the shares at $5.96 per share, which was the company’s closing price on December 3, 2025, the most recent closing price available.

How many CEL-SCI (CVM) shares does Geert Kersten own after this transaction?

After the reported purchase, Geert Kersten beneficially owns 81,794 shares of CEL-SCI common stock in direct ownership.

What is Geert Kersten’s role at CEL-SCI Corp (CVM)?

Geert Kersten is listed as both a Director and an Officer, serving as the company’s Chief Executive Officer.

What type of SEC filing is this for CEL-SCI Corp (CVM)?

This is a Form 4 filing, which discloses changes in the ownership of the company’s equity securities by an insider such as a director or executive officer.

Was the CEL-SCI (CVM) insider transaction a purchase or a sale?

The Form 4 shows a transaction code of P, indicating a purchase of common stock by Geert Kersten.

CEL-SCI Corp

NYSE:CVM

CVM Rankings

CVM Latest News

CVM Latest SEC Filings

CVM Stock Data

43.31M
7.76M
8.18%
6.18%
11.14%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
VIENNA